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Abstract
As gene expression measurement technology is shifting from microar-
rays to sequencing, the statistical tools available for their analysis must
be adapted since RNA-seq data are measured as counts. Recently, it
has been proposed to tackle the count nature of these data by modeling
log-count reads per million as continuous variables, using nonparamet-
ric regression to account for their inherent heteroscedasticity. Adopting
such a framework, we propose tcgsaseq, a principled, model-free and ef-
ficient top-down method for detecting longitudinal changes in RNA-seq
gene sets. Considering gene sets defined a priori, tcgsaseq identifies those
whose expression vary over time, based on an original variance component
score test accounting for both covariates and heteroscedasticity without
assuming any specific parametric distribution for the transformed counts.
We demonstrate that despite the presence of a nonparametric component,
our test statistic has a simple form and limiting distribution, and both
may be computed quickly. A permutation version of the test is addition-
ally proposed for very small sample sizes. Applied to both simulated data
and two real datasets, the proposed method is shown to exhibit very good
statistical properties, with an increase in stability and power when com-
pared to state of the art methods ROAST, edgeR and DESeq2, which can
fail to control the type I error under certain realistic settings. We have
made the method available for the community in the R package tcgsaseq.
Key words: Gene Set Analysis; Longitudinal data; RNA-seq data; Vari-
ance component testing; Heteroscedasticity
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1 Introduction
Gene expression is a dynamic biological process of living organisms, whose dys-
function and variation can be related to numerous diseases. During the past two
decades, gene expression measurements have developed rapidly, thanks to wide
dissemination of microarray technology. In recent years, gene expression mea-
surement technology has been shifting from microarrays to sequencing (RNA-
seq) technology. The higher resolution of RNA-seq technology provides a num-
ber of advantages over microarrays, among which are the ability to make de novo
discoveries and an increased sensitivity to low abundance variants (Marioni and
others, 2008; Malone and Oliver, 2011). Indeed, RNA-seq is not restricted to a
predefined set of probes like microarrays but can instead measure the genome
in its entirety.
A large body of statistical methods have been developed to analyze microar-
ray data. But as technology for measuring gene expression is transitioning to
RNA-seq, new methodological challenges arise. RNA-seq produces count data,
while microarray analysis techniques generally assume continuity. Due to their
underlying count nature, RNA-seq data are intrinsically heteroscedastic. Vari-
ous approaches have been proposed to deal with these issues, mostly relying on
modeling the underlying count nature of the data through the use of Poisson or
negative binomial distributions (Marioni and others, 2008; Anders and Huber,
2010; Robinson and others, 2010). Recently, Law and others (2014) have instead
proposed to use normal-based methods to analyze RNA-seq data by explicitly
modeling the heteroscedasticity and accounting for it by weighting.
While most methods for gene expression data focus on univariate differential
gene expression analysis, it has been shown that gene set analysis (GSA) can be
a more powerful and interpretable alternative (Subramanian and others, 2005;
Hejblum and others, 2015). GSA uses a priori defined gene sets annotated with
biological functions and investigates their potential association with biological
conditions of interest. Typically, GSA is defined by the type of hypothesis tested
and the method of aggregating information across genes. There are two primary
approaches to specifying hypotheses: self-contained hypotheses and competitive
hypotheses (Goeman and Bu¨hlmann, 2007). Rahmatallah and others (2016)
recently showed that self-contained tests tend to be more powerful and more
robust than competitive ones. Furthermore, some GSA tests rely on gene-level
univariate statistics as a first step, using a bottom-up enrichment approach.
However, when signal strength is weak, single-step, top-down approaches relying
on multivariate modeling better leverage the additional power of GSA (Hejblum
and others, 2015).
Another concern, particularly in the longitudinal setting, is adequately ac-
counting for heterogeneity of effects (Cui and others, 2016). GSA approaches
often overlook the potential longitudinal heterogeneity within a gene set while
such heterogeneity is not infrequent (Ackermann and Strimmer, 2009) and can
be of biological interest (Prieto and others, 2006; Hu and others, 2013), espe-
cially if considered gene sets correspond to biological pathways. Hejblum and
others (2015) showed the potential statistical power gain by accounting for this
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heterogeneity in longitudinal microarray studies.
As costs keep decreasing for RNA-seq experiments, more complex study de-
signs, such as time-course experiments, have become more common (Nueda and
others, 2014; Dorr and others, 2015; Leng and others, 2015; Baduel and others,
2016). However, very few GSA approaches can properly accommodate and test
hypotheses more complex than simple differential expression, such as change
over time. The ROAST method (Wu and others, 2010), which is a linear-
model-based testing procedure that can make use of the weighting in Law and
others (2014), has been identified in the recent review by Rahmatallah and
others (2016) as one of the top-performing GSA methods for RNA-seq data.
Among the eleven methods compared in the review, only three are derived from
top-down models incorporating all the genes in the set at once, and ROAST is
the only one that is not limited to comparisons of two groups. Additionally, DE-
Seq2 (Love and others, 2014) and edgeR (Robinson and others, 2010; McCarthy
and others, 2012), are currently the most prominent approaches used for gene
level differential analysis of RNA-seq data. They both rely on the assumption
that gene counts from RNA-seq measurements follow a negative binomial dis-
tribution. edgeR uses the ROAST method to propose a built-in framework for
self-contained gene set testing, while DESeq2 can only perform gene-wise tests.
In this article, we propose tcgsaseq, a method to analyze RNA-seq data at
the gene-set level, with a particular focus on longitudinal studies. We derive
a variance component score test, similar to those that have been proposed in
other testing situations (Wu and others, 2011; Huang and Lin, 2013), that fa-
cilitates testing both homogeneous and heterogeneous gene sets simultaneously.
Variance component tests offer the speed and simplicity of standard score tests,
but potentially gain statistical power by using many fewer degrees of freedom.
Inspired by the voom approach (Law and others, 2014), we propose to estimate
the mean-variance relationship in a more principled way using local linear re-
gression, to account for the inherent heteroscedasticity of the data. Despite this
nonparametric step, we demonstrate that the test statistic has a simple limiting
distribution that is valid regardless of any model specification. We also propose
a permutation version of the test to deal with small sample sizes. Our method
is implemented in the R package tcgsaseq, available on the Comprehensive R
Archive Network at https://cran.r-project.org/web/packages/tcgsaseq.
Our general approach to GSA in longitudinal RNA-seq studies has three pri-
mary advantages over existing approaches. First, unlike ROAST, our variance
component approach remains valid under model misspecification and does not
rely on ad hoc aggregation of information across genes. Second, unlike previous
approaches to variance component testing in microarray data (Huang and Lin,
2013), our approach can accommodate the intrinsic mean-variance relationship
in RNA-seq data, while remaining fast to compute. Third, our test remains
powerful even when patients display heterogeneous trajectories over time.
The remainder of the paper is organized as follows. Section 2 describes
our variance component score test, while its asymptotic properties are derived
in Section 3, and an estimation strategy and practical recommendations are
detailed in Section 4. In Section 5, we present numerical studies assessing the
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potential impact of ignoring the mean-variance relationship in RNA-seq data,
and comparing our approach to state of the art methods of gene set analysis.
In Section 6, we apply tcgsaseq to the analysis of real data. Final remarks and
comments are discussed in Section 7.
2 Variance component score test for longitudi-
nal gene set analysis
2.1 Problem setup
Consider ri = (r
T
i1, ..., r
T
iP )
T, rij = (rij1, ..., rijni)
T a vector of sequence read
counts for subject i, that have been mapped to each of P genes measured at
times ti = (ti1, ..., tini)
T. Meanwhile xi = (xi1, ..., xiq)
T is a vector of baseline
covariates describing experiment design conditions, all measured on individual
i. So the full data considered for analysis are n independent realizations from
random vectors V = {Vi = (rTi , tTi ,xTi )T}ni=1. Typically, the counts ri are nor-
malized in some way in a preprocessing step (Hansen and others, 2012; ?). We
take yi to be a normalized version of ri. For example, one standard normaliza-
tion procedure accounts for the library size Lit =
∑P
j=1 rijt by computing the
log-counts per million as
yijt = log2
(
106 × 0.5 + rijt
1 + Lit
)
. (1)
Based on these data, our interest is in identifying gene sets that have lon-
gitudinally changing expression patterns. The rest of this section will develop
the proposed test statistic and its limiting distribution.
2.2 The test statistic
We are interested in testing for longitudinal changes in a pre-specified gene
set, which for the purposes of illustration we take to be the first p genes, yi =
(yi1, ...,yip). To develop a variance component score test statistic, we start from
the following working model, which is a linear mixed effect model:
yijt = α0j + a0ij + x
T
iαj + φ
T
itβj + φ
T
itξij + ijt (2)
and which can be rewritten as
yi = α0 + a0i +Xiα+ Φiβ + Φiξi + εi (3)
ξi = (ξ
T
i1, ..., ξ
T
ij)
T ∼ N(0,Σξ), εi ∼ N(0,Σεi), a0i ∼ N(0,Σa) (4)
where α0 is a pni × 1 vector of gene-specific intercepts α0j , a0i is a pni × 1
vector of random intercepts a0ij , Xi is a pni × pq block diagonal matrix with
each block consisting of ni rows equal to the fixed effect baseline covariates xi,
α is a pq × 1 vector of gene-specific fixed effects αj , Φi = Φ(ti) is a pni × pK
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block-diagonal matrix encoding the effect of time with each block having tth
row φit = {φ1(tit), ..., φK(tit)} for some set of K basis functions {φk(·)}, β is
a pK × 1 vector of gene-specific fixed effects of time βj , ξi is a pK × 1 vector
of gene-specific random effects of time, Σξ = Cov(ξi, ξi), and Σεi is a pni × pni
covariance matrix of measurement errors. Note that Σεi is indexed by i and
may depend on the mean of yi. We assume that a0i ⊥ εi. It is important to
note that, in practice, this model is unlikely to hold. Fortunately the testing
procedure we propose is entirely robust to its misspecification.
We are interested in testing the null hypothesis of no longitudinal change in
the normalized gene expression for any genes in the gene set
H0 : The mean of yi does not depend on ti (5)
or, that is, E(yi|ti) = E(yi) and E(yi|ti,xi) = E(yi|xi). Under the model (3),
the null hypothesis (5) corresponds to the following null: H0 : β = ξi = 0. In
section 3, we demonstrate that the corresponding variance component score test
can be written as
Q = qTq, qT = n−
1
2
n∑
i=1
yTµiΣ
−1
i ΦiΣ
1/2
ξ (6)
where Σi = Σa+Σεi, yµi = yi−α0−Xiα and Σ1/2ξ is the symmetric half matrix
such that Σ
1/2
ξ Σ
1/2
ξ = Σξ. We also show in the Supplementary Material that,
given the dimension of q (pK) is small relative to the number of individuals
(n), the asymptotic distribution of the test statistic is a mixture of χ21 random
variables, Q −→ ∑pKl=1 alχ21, where the mixing coefficients {al} depend on the
covariance of q. In the end, p-values may be computed by comparing the ob-
served test statistic Q to the distribution of
∑pK
l=1 âlχ
2
1 where âl is an estimate of
al. Details are developed further in Section 3 and the Supplementary Material.
When the entries of q are correlated – i.e. there is correlation between genes
in the gene set – then the degrees of freedom for the test based on Q (
∑pK
l=1 al)
may be much lower than the degrees of freedom for a similar Wald or score test
(pK), yielding more power to detect departures from the null hypothesis.
In practice, the parameters α0, α, Σi, and Σξ are unknown and must be
estimated. In particular, accounting for the mean-variance relationship encoded
in Σi is vital in RNA-seq data. Hence we estimate the test statistic as
Q̂ = q̂Tq̂, q̂T = n−
1
2
n∑
i=1
(yi − α̂0 −Xiα̂)TΣ̂−1i ΦiΣ̂1/2ξ (7)
and we further demonstrate in section 3 that plugging in standard estimates
of Σξ, α0, and α and a nonparametric estimator of Σi for the estimated test
statistic still yields a similar asymptotic distribution:
Q̂ −→
pK∑
l=1
a˜lχ
2
1 (8)
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for mixing coefficients {a˜l} given in the Supplementary Material.
The strength of our approach is that this simple limiting distribution holds
even when the model (3) may be misspecified and despite the presence of the
nonparametric estimator of Σi in (7). In this way, we may account very flexibly
for the mean-variance relationship in y while maintaining a simple, powerful
test statistic that does not require any particular model to hold.
The convergence in (8) relies on the central limit theorem. There may of
course be situations where the central limit theorem fails to kick in, either when
the number of genes in the gene set p is quite large, or else when the number of
individuals n is small. We now discuss two modifications for these scenarios.
2.2.1 Testing for homogeneous gene sets
When the number of genes p is large relative to n, the convergence of q to a
limiting normal distribution may be in doubt. In these cases, it might be better
to begin from a working model that assumes that all genes share a common
trajectory over time, as a useful approximation. To wit, we may reduce the
number of parameters in the model by taking Xi in model (3) to be a pni × q
counterpart of Xi, and similarly α to be q × 1, Φi to be pni ×K, and ξi to be
K × 1 counterparts, respectively, of the original quantities.
The derivation of the test statistic in this case follows precisely the same lines,
once dimensions are updated. This test will be powerful to detect alternatives
where all genes in the set develop in a similar fashion longitudinally. However,
this test should be expected to have low power to detect situations where some
genes, for example, decline over time while other genes increase over time, as in
heterogeneous gene sets.
2.2.2 Using permutation
When n is very small (or alternatively when p is relatively large but the ho-
mogeneous strategy described above seems unwise), relying on the limiting dis-
tribution (7) may not be accurate. In these cases, permutation may be used
to estimate the empirical distribution of Q̂ under the null (5). To perform the
permutations, we simply shuffle the time labels within each individual to get
permuted observations for the ith individual y∗ijt = yijIt where {I1, ..., Ini} is
a permutation of {1, ..., ni}. Indeed, under the null, observations of a given
gene j for a given individual i are exchangeable, regardless of sampling time. A
large number B of permutation-based test statistics Q = {Q∗1, ..., Q∗B} can thus
be generated where each Q∗b is computed using the bth set of permuted data.
P-values may then be computed as:
p̂ =
1
B
B∑
b=1
I{Q̂ ≤ Q∗b} (9)
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3 Properties of the test statistic
In this section, we derive the test statistic and demonstrate its asymptotic dis-
tribution assuming all parameters known. We then take up the distribution of
the test statistic when estimating all relevant parameters.
3.1 Test statistic derivation
Under the working model (3), yi|a0i, ξi,xi, ti ∼ N(α0 + a0i + Xiα + Φiβ +
Φiξi,Σεi). Integrating over the random intercepts a0i, we can rewrite the model
as
yi|ξi,xi, ti ∼ N(µi + Φiθi,Σi) (10)
where µi = α0+Xiα denotes time-independent fixed effects, θi = (β
T
1 + ξ
T
i1, . . . ,
βTp + ξ
T
ip
)T
denotes combined effects of time.
The test for no longitudinal changes in expression corresponds to the model-
based hypothesis H0 : θi = 0. We write θi as θi = ηνi and we consider
the working assumption that the {νi} are independently distributed such that
E(νij) = 0 (under the null) and Var(νij) = Σξ. Under this working assumption,
H0 : θi = 0 is equivalent to H0 : η = 0. To obtain the variance component
test statistic, rewrite the model as: yµi = Φiθi + εi for centered outcome
yµi = yi −µi. Then yµi|νi,∼ N (Φiηνi,Σi) and the log-likelihood for yµi can
be written as
logL(η) = −1
2
n∑
i=1
{
log |Σi|+ (yµi − ηΦiνi)T Σ−1i (yµi − ηΦiνi)
}
. (11)
Because the target of inference is η, we marginalize over the nuisance parameter
ν conditional on the observed data to obtain L∗(η) = E{L(η)|V} where the
expectation is taken over the distribution of ν. We follow the argument in
Commenges and Andersen (1995) and note that the score at the null value is
0: limη→0 ∂ logL∗(η)/∂η = E
(∑n
i=1 y
T
µiΣ
−1
i ην
T
iφi | V
)
= 0. So we instead
consider the score with respect to η2, limη→0 ∂ logL∗(η)/∂(η2), and
E
{
∂ logL(η)
∂η
∣∣∣∣
η=0
| V
}2
+ constant + op(1) (12)
= E
(
η
n∑
i=1
yTµiΣ
−1
i Φiνi | V
)2
+ constant + op(1) (13)
=
(
n∑
i=1
yTµiΣ
−1
i Φi
)
Σξ
(
n∑
i=1
yTµiΣ
−1
i Φi
)T
+ constant + op(1) (14)
Thus, after normalizing by n−1, the variance component score test statistic can
be written Q = qTq, as described in (6). If the dimension of q is small relative to
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the sample size, q is asymptotically normal by the central limit theorem, which
means that the limiting distribution of Q is a mixture of χ21s (see Supplementary
Material for more details).
3.2 Estimated test statistic limiting distribution
In practice, estimates need to be supplied for many of the quantities in the
test statistic to be estimated in (7). Following the argument for the limit-
ing distribution of Q, Q̂ has a limiting distribution of a mixture of χ21s so
long as q̂ has a limiting normal distribution. To establish this, we define
q˜ = n−
1
2
∑n
i=1(yi − µ̂i)TTi to be a version of q̂ where Σ̂−1i ΦiΣ̂1/2ξ is replaced
with its limit, Ti = limn→∞ Σ̂−1i ΦiΣ̂1/2ξ . The quantities q̂ and q˜ are asymptot-
ically equivalent, and the central limit theorem ensurea that q˜ has a limiting
normal distribution. This further suggests that the asymptotic distribution of
Q̂ is a mixture of χ21s (see Supplementary Material for details).
4 Estimation
The test statistic (7) contains the estimated quantities α̂0, α̂, Σ̂ξ, and Σ̂i. In
this section, we take up practical issues involved in the estimation of these
quantities.
4.1 Estimating model parameters
In this section, we will discuss estimation of (α̂0, α̂, Σ̂ξ), assuming that we have
a consistent estimator of Σ̂i in hand (we leave discussion of estimating Σ̂i to the
following section). A natural way to estimate (α̂0, α̂, Σ̂ξ), taking into account
the heteroscedasticity in y, is to fit a weighted mixed effects model corresponding
to
yijt = α0j + x
T
iαj + φ
T
itβj + φ
T
itξij + ˜ijt, (15)
where the random intercepts a0ij have been integrated out. The weights are
taken to be wi = diag(Σ̂i)
−1. This model corresponds to the model (10).
In practice, fitting the full mixed effects model for each of many gene sets
may be computationally demanding. In these cases, the simpler fixed effects
model
yijt = α0j + x
T
iαj + φ
T
itβj + ˜ijt (16)
may be fit to estimate α0 and α. Σξ may not be estimated directly from (16).
In this case, it may be specified using a working estimate or taken to be the
identity matrix.
8
4.2 Estimating the mean-variance relationship
One key feature of our approach is to estimate Cov(yi|xi, ti, ξi) = Σi in such
a way as to account for the heteroscedasticity in y. It is important to note
that accurate estimation of Σi will likely increase power but will not affect the
validity or type I error of the testing procedure.
To approximate the mean-variance relationship in y, we use information
from all P genes. We assume that the diagonal elements of Σi, which we will
denote v = {vijt} = {Var(yijt|xi, ti, ξi)}, may be modeled as a function of their
means m = {mijt} = {E(yijt|xi, ti, ξi)}. Specifically, vijt = ω{mijt} + eijt
for some unknown function ω(·) and errors which follow the moment conditions
E(eijt) = 0,Var(eijt) = τ
2, τ > 0.
We follow Law and others (2014) in using local linear regression in estimating
ω(·). We will first write out the form of the estimator if all parameters were
known
ω˜n(x) =
∑
ijt
˜`
ijt(x)vijt, ˜`ijt(x) =
b˜ijt(x)∑
ijt b˜ijt(x)
(17)
b˜ijt(x) = K{(mijt − x)/h}
{
S˜n2(x)− (mijt − x)S˜n1(x)
}
(18)
where S˜nd(x) =
∑
ijtK{(mijt−x)/h}(mijt−x)d for some kernel function K(·)
and bandwidth h > 0.
The means m and variances v could in principle be estimated using some
parametric model like (15) for all P genes. Let (m̂ijt, v̂ijt) denote the esti-
mated mean and variance for yijt. Then the mean-variance relationship may be
estimated as
ω̂n(x) = ω˜n(x)|mijt=m̂ijt,vijt=v̂ijt (19)
As with any smoothing procedure, choice of the bandwidth h is paramount
in producing a reliable estimator. Standard cross-validation techniques may be
used to select h in practice. Then the diagonal entries of Σi can be estimated
as ω̂n(m̂i).
Practical considerations Under the model (15), we could take m̂ijt = α̂0j+
xTitα̂j+φ
T
itβ̂j+φ
T
itξ̂ij and v̂ijt = (yijt−α̂0j−xTitα̂j−φTitβ̂j−φTitξ̂ij)2. However,
because P  n, fitting (15) for such a large number of genes is not practical.
Instead, the simpler model (16) could be used. Then m̂ijt could be taken to
be α̂0j + x
T
itα̂j + φ
T
itβ̂j and v̂ijt to be (yijt − α̂0j − xTitα̂j − φTitβ̂j)2. A similar
approach was used to model heteroscedasticity in the context of linear regression
in Carroll (1982).
On the other hand, fitting a local linear regression on all of m and v – a
total of P
∑n
i=1 ni observations – may be computationally difficult. In order to
reduce the number of points used in the nonparametric fit (19), one could follow
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Law and others (2014) and model the mean-variance relationship at the gene
level
vj = ω(mj) + ej . (20)
The gene-level mean may be estimated as m̂j = n
−1∑n
i=1 n
−1
i
∑ni
t=1 α̂0j +
xTitα̂j + φ
T
itβ̂j and the gene-level variance as v̂j = n
−1∑n
i=1 n
−1
i
∑ni
t=1(yijt −
α̂0j − xTitα̂j − φTitβ̂j)2.
5 Numerical study
In this numerical study section, we illustrate both the importance of accounting
for RNA-seq data’s heteroscedasticity and the superiority of tcgsaseq in terms of
statistical power and robustness. We have performed simulations under two dif-
ferent settings. The first one demonstrates the good behavior of the asymptotic
test under various scenarios in synthetic data. The second one focuses on a very
realistic situation where sample size is small and gene counts are generated from
a distribution of real observed RNA-seq data. Throughout, for the purposes of
testing, we take Σa and Σξ to be the identity for simplicity. In practice, more
precise estimation of Σa and Σξ would serve to increase power.
5.1 Synthetic data
In this subsection, we use synthetic data to illustrate the behavior of our esti-
mator when the distribution of the data is known. We first look at the impor-
tance of accounting for the mean-variance relationship in Σi in tcgsaseq, and
then we will compare tcgsaseq to other competing methods, including ROAST,
edgeR-ROAST, and DESeq2. In order to adapt DESeq2 to self-contained gene
set testing, we use the minimum p-value test to adequately combine univariate
p-values for testing a whole gene set while taking into account gene correla-
tion (Moskvina and Schmidt, 2008; Lin and others, 2011) and we refer to it
as DESeq2-min test. We demonstrate that the tcgsaseq testing procedure is
robust to even heavy misspecification of the mean model and the mean-variance
relationship, while ROAST, edgeR-ROAST and DESeq2-min test may suffer
from extreme lack of power compared to tcgsaseq or inflate type I errors under
misspecification.
5.1.1 Mean-variance relationship
To illustrate the importance of estimating the mean-variance relationship, we
generated data under the model yijt = log
{
(µijt + 0.5)10
6∑
i µijt + 1
}
where
µijt = ηijt
∑
i,t
ηijt/P + bijtit + βtit, ηijt = aij + αj +
3∑
k=1
xitk + ijt, (21)
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with ijt ∼ N(0, α2j ), αj ∼ exp(100), aij ∼ N(0, α2j/100), xitk ∼ N(100, 2500),
tit ∼ U(0, 1), bij ∼ N(0, 1). We set n = 200, p = 10, P = 1000, ni = 3,
and β was allowed to be set to 6 different values within a range from 0 to
2: (0, 0.5, 0.75, 1, 1.25, 1.5, 2). We considered three methods of accounting for
the mean-variance relationship: (i) gene-level estimates using equation (20);
(ii) voom-type estimation Law and others (2014); (iii) specifying Σi to be the
identity. Throughout this section we test at the 0.05 level. The model (16) was
used to generate the test statistic and adjust for covariates, and the gene-level
equation (20) was used to estimate the mean-variance relationship. Note that
the mean model (16) is misspecified.
When applying our variance component test, type I error was at the nominal
level using either strategy (i) or (iii), but was deflated to 0.035 when using
strategy (ii). On the other hand, ROAST, which similarly relies on estimating
the mean-variance relationship, inflated type I error to 0.56 when using (ii), and
had adequate type I errors using the other weighting strategies. Such results
indicate that ROAST may drastically inflate type I error rates in some cases,
and that using (ii), the voom-type estimator, to account for heteroscedasticity
led to worse performance in general.
Figure 1 demonstrates the effect of accounting for heteroscedasticity under
the alternative hypothesis. The more accurate modeling of the mean-variance
relationship with method (i) yields large power gains over method (ii). Con-
versely, by drastically mis-modeling the mean-variance relationship, the naive
method (iii) yields almost no power for detecting longitudinal changes.
0.00
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1.00
0 0.5 0.75 1 1.25 1.5 2
beta
Po
w
e
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Estimation
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(ii) voom
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5%
Figure 1: Power evaluation in synthetic data according to how heteroscedasticity
is accounted for, based on 1,000 simulations.
5.2 Comparison to competing methods
In this subsection, we compare tcgsaseq to ROAST, edgeR-ROAST, and DESeq2-
min test using a highly misspecified model and using a negative binomial model.
For the misspecified model, we again generate data under model (21) with one
modification to ensure that the data are positive integers yijt =
11
max
{⌈
log
(
(µijt+0.5)10
6∑
i µijt+1
)⌉
, 1
}
. We set n = 50, 100, 150 and ni = 5, and β took
values between -2 and 2. Because DESeq2 is computationally intractable at
higher sample sizes with large P , we set the total number of genes P to be
100. We used model (20) to compute the mean-variance relationship for both
tcgsaseq and ROAST. Gene-based estimates were used for dispersions in DE-
Seq2, and likelihood ratio tests were used to produce test statistics for both
edgeR and DESeq2.
The results are depicted in Figure 2. We see that tcgsaseq has the highest
power at all sample sizes and at all values of β. Though the model is highly mis-
specified for all methods, the negative-binomial-based methods edgeR-ROAST
and DESeq2-min test suffer greatly in terms of power, in particular DESeq2-
min test. In Figure 2, we show ROAST using the mean-variance relationship
estimated from model (20), but it’s important to note that if the voom-type
strategy were used, the type I error for ROAST rises to more than 0.1 at all
sample sizes.
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Figure 2: Power evaluation in synthetic data comparing tcgsaseq, ROAST,
edgeR-ROAST, and DESeq2-min test, based on 1,000 simulations.
Secondly, we generated data under the negative binomial model, a distri-
butional assumption that edgeR and DESeq2 make. The mean of the negative
binomial was specified as
µijt = max{1001 + a0i + xi + (bi + β + βj)titxi, 0} (22)
where a0i ∼ N(0, 1), xi ∼ N(µxi, 1), µxi ∼ exponential(1/10), bi ∼ N(0, 1), βj ∼
N(0, 1), and the negative binomial dispersion parameter was set to 1. We again
let β vary between -2 and 2 and considered sample sizes of n = 50, 100, 150. In
this setting, the default procedure to estimate dispersions was used for DESeq2.
The results depicted in Figure 3 show that tcgsaseq and ROAST outperform
edgeR-ROAST and DESeq2-min test despite the fact that the distributional
assumptions of edgeR and DESeq2 are true. The performance of tcgsaseq and
ROAST is in general comparable. Furthermore, it is important to highlight that
DESeq2-min test does not control the type I error, and the type I error gets
worse as sample size increases.
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Figure 3: Power evaluation in negative binomial data comparing tcgsaseq,
ROAST, edgeR-ROAST, and DESeq2-min test, based on 1,000 simulations.
5.3 Realistic small samples simulations
In this subsection, we simulated another dataset to illustrate the good behavior
of the tcgsaseq permutation test in the realistic setting of a small sample size.
We generated data for 6 individuals each measured at 3 time points according
to the scenario described in Law and others (2014), using the script provided in
their Supplementary Material:
mij = 0.2 + 1/
√
µij + βtit and yijt = log
(
(aij + 0.5)10
6∑
j aij + 1
)
(23)
where tit ∈ {1, 2, 3}, aij ∼ Pois(λij), λij ∼ Gamma( κij40mij ,
40mij
κijµij
), κij ∼ χ2(40),
and µij follows an empirical baseline distribution derived from real RNA-seq
counts data, provided in supplementary material of Law and others (2014).
This simulation scheme allows us to generate data that realistically resemble
real RNA-seq count data. We set n = 6 with ni = 3, and gene sets were
constructed such that p ∈ (30, . . . , 400) and for every gene pair (j, j′) in the set
cor(µj ,µj′) > 0.8. β was allowed to be set to 8 different values within a range
from 0 to 0.5: (0, 0.01, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5).
As shown in Figure 4, under this setting, edgeR-ROAST, ROAST and the
proposed permutation test all control the type I error at nominal rate. However
DESeq2-min test fails to control the type I error, while it is highly deflated for
the asymptotic version of tcgsaseq (0.001) which is not surprising given that with
such a small sample size it is unlikely the central limit theorem would have come
into effect yet. Nonetheless, we observe a steady and consistent increase of power
for our method using the permutation test over the compared state of the art
approaches. The deviation from the negative binomial distribution hypothesis
(which both edgeR and DESeq2 rely upon), as well as the univariate gene-
wise step first needed, explain those poor performances compared to tcgsaseq.
Similar results are obtained when adding a random effect of time simulating
heterogeneous gene sets (see Supplementary Material). In addition, as gene sets
were constructed with correlated genes, these results also indicates that tcgsaseq
is robust to and can take advantage of inter-gene correlation.
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Figure 4: Power evaluation in realistically simulated data with a small sample
size, based on 500 simulations.
6 Application to two real datasets
In this section we present analyses of two real datasets. In both analyses, Σa
and Σξ were again taken as the identity while Σi was estimated at the gene level
using equation (20) for tcgsaseq. The ROAST method was applied in combina-
tion with precision weights estimated through the voom approach. Given the
sample sizes available in both studies, we used the tcgsaseq permutation test.
In both case, only transformed data were available and not original counts data,
preventing us from applying either edgeR-ROAST or DESeq2-min test.
6.1 Longitudinal RNA-seq measurements in successful kid-
ney transplant patients
We analyzed a RNA-seq dataset from Dorr and others (2015), in which gene
expression was measured in the peripheral blood mononuclear cells of 32 kidney
transplant patients. Gene expression was measured at 4 time points: before
transplantation, 1 week after transplantation, 3 months after transplantation
and 6 month after transplantation. The patients had had no graft rejection at
the time of each sample.
We investigated custom gene sets targeted specifically towards kidney trans-
plant. Those kidney-oriented gene sets were derived by the Alberta Trans-
plant Applied Genomics Center from specific pathogenesis-based transcripts
(Halloran and others, 2010; Sellare´s and others, 2013; Broin and others, 2014),
and their definition is available at http://atagc.med.ualberta.ca/Research/
GeneLists. We tested for a linear change in gene expression over time while
adjusting for patient’s age and gender.
Figure 5 shows the p-values for those 9 gene sets for both tcgsaseq and
14
ROAST. At a 5% threshold, our approach tcgsaseq identifies three significant
gene sets while the combination of voom and ROAST identifies none. Among
those significant gene sets, two relate to T-cell gene expression, corroborating
the original results from Dorr and others (2015). The gene set annotated as
”T-cells” notably includes the gene CD3D, previously highlighted in Dorr and
others (2015). On the contrary, gene sets related to transplant rejection such as
”Donor-specific antibody” or ”Gamma-IFN and Rejection” have a much higher
p-value here, which is what one would expect as these data include only suc-
cessful transplant patients. Besides, tcgsaseq also detects a significant change
in expression for the gene set related to Mast cells, which have recently been
highlighted as playing an ambiguous role in kidney transplant (Papadimitriou
and others, 2013). Mast cells have been linked both to peripheral tolerance
(de Vries and others, 2009), as well as to late graft loss Jevnikar and Mannon
(2008). These results both reinforce and broaden the original findings from Dorr
and others (2015).
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Figure 5: P-values from testing the 9 kidney oriented gene sets investigated
6.2 Time-course RNA-seq comparative study ofArabidop-
sis arenosa physiology
In a recent experiment, Baduel and others (2016) measured time-course gene
expression of the plant Arabidopsis arenosa through RNA-seq. They sampled
48 plants across 13 weeks at four different time points. Baduel and others
(2016) were especially interested in the difference between two populations of
Arabidopsis arenosa, respectively denoted KA and TBG, that have adopted
different flowering strategies. In addition, half of the plants were exposed to
cold and short day photoperiods (vernalization) between week 4 and week 10
in order to study the corresponding effect on flowering in both populations.
Different plant siblings were sampled at each time points in order to avoid the
important stress effect of leaf removal on the plants.
Dealing with this complex experiment design, we used tcgsaseq to address
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two separate biological questions: i) which gene sets have a different activation
between the two populations, adjusted for the plant age and the cold exposure,
ii) which gene sets have a different activation due to cold exposure, adjusted for
population differences and plant age. Using two different modeling strategies,
we found that one data-driven gene set constructed by Baduel and others (2016)
from the top 1% differentially expressed genes between the two populations was
significant at a 5% threshold for i) and for ii). On the contrary two other data-
driven gene sets, again constructed by Baduel and others (2016) and identified
as the respective population-specific responses to cold exposure, were both sig-
nificant at this 5% threshold for ii) but not for i). In addition, two gene sets
from Gene Ontology associated with salt and cold response pathways, respec-
tively, were also investigated and found significant at the 5% level for ii) but not
for i). In comparison, ROAST gave similar results for i), but lacked power for
ii) identifying only 1 out of 4 significant gene sets. This analysis corroborates
the results obtained by Baduel and others (2016), and it further illustrates the
good behavior of tcgsaseq in complex time-course RNA-seq studies.
7 Discussion
The proposed method detailed in this article constitutes an innovative and flex-
ible approach for performing gene set analysis of longitudinal RNA-seq gene
expression measurements. The approach relies on a principled variance com-
ponent score test that accounts for the intrinsic heteroscedasticity of RNA-seq
data, and for which we derive a simple limiting distribution without requiring
any particular model to hold. As illustrated in the previous sections, the good
performance of the method when applied to various datasets constitutes a major
strength of the method.
Our numerical study shows the importance of taking into account het-
eroscedasticity when analyzing RNA-seq data. We also demonstrate the robust-
ness of our testing procedure to model misspecification. When comparing our
proposed approach to ROAST, a state-of-the-art GSA method suitable for lon-
gitudinal studies, we illustrate superior statistical power. In addition, ROAST
relies on the correct specification of a linear model and normality of errors, while
our testing procedure does not make any modeling assumptions. Furthermore,
despite their growing popularity, RNA-seq studies may yet face small sample
sizes. In order to deal with this issue, we provide a permutation alternative to
our asymptotic test. This alternative test also exhibits very good properties in
our simulation studies.
We show that widely used methods such as ROAST, edgeR or DESeq2 are
unfit for time course gene set analysis. In realistic settings, those methods can
fail to control the Type I error. And even in favorable settings, the proposed
method outperforms all of them in terms of statistical power.
Of particular biological interest in longitudinal studies, the proposed ap-
proach can test for both homogeneous and heterogeneous gene sets simulta-
neously. This is especially relevant for gene sets constructed from biological
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pathways. It also results in a power gain compared to GSA methods sensitive
only to homogeneous sets. In addition, the proposed solution for accounting for
heteroscedasticity can also deal with non-count data.
As demonstrated by the simulation study, the proposed approach is also ro-
bust to inter-gene correlation within tested gene sets. While in our simulations
we do not estimate inter-gene correlations, one could account for them more
formally by following Wang and others (2009) and estimating a working corre-
lation matrix with the residuals from an initial gene-wise modeling of y. The
resulting estimates could be incorporated into the structure of Σi to increase
power.
Finally, in this paper we focus primarily on longitudinal measurements of
RNA-seq. However, our approach directly applies to virtually all RNA-seq
study designs, including traditional case-control and more complex studies. Our
approach allows researchers to incorporate the natural heteroscedasticity in the
data into a powerful test statistic that makes no modeling assumptions. Of
note, the inclusion of time-varying covariates would require further assumptions
concerning the model to be made to ensure the limiting distribution of the test
statistic. Evaluating tcgsaseq’s performance in a broader array of studies is an
area for future research.
Software
Software in the form of R code is available on the Comprehensive R Archive
Network as an R package tcgsaseq.
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Supplementary Material
S.1 Properties of the test statistic
In this section, we establish the limiting distribution of the quantity Q and its
estimated counterpart Q̂.
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S.1.1 Limiting distribution of Q
Recall that Q = qTq. Let Γ = Cov(q). Then
Q = qTΓ−1/2ΓΓ−1/2q (24)
= uTUAU Tu+ op(1) (25)
where U is an orthonormal matrix of the eigenvectors of Γ, A is a diagonal matrix
of the eigenvalues of Γ, and u = Γ−1/2q is asymptotically standard multivariate
normal by the central limit theorem. Noting that, because U is orthonormal,
U Tu is also asymptotically standard normal, uTUAU Tu =
∑pK
k=1 ak(u
∗
k)
2 where
u∗k is an element of the asymptotically standard normal U
Tu and ak an eigen-
value of Γ. It finally follows that Q ∼∑pKl=1 alχ21.
S.1.2 Limiting distribution of Q̂
Recall that Q̂ = q̂Tq̂. We first show that q̂ and q˜ are asymptotically equivalent.
q̂T − q˜T = n− 12
n∑
i=1
(yi − µ̂i)TΣ̂−1i ΦiΣ̂1/2ξ − n−
1
2
n∑
i=1
(yi − µ̂i)TTi (26)
= n−
1
2
n∑
i=1
(yi − µ̂i)T(T̂ (x˜i)− T (x˜i)) (27)
for the processes T (x˜i) = Σ(x˜i)−1Φ(x˜i)Σ1/2ξ = Σ−1i ΦiΣ1/2ξ and T̂ (x˜i) =
Σ̂(x˜i)
−1Φ(x˜i)Σ̂
1/2
ξ = Σ̂
−1
i ΦiΣ̂
1/2
ξ as a function of x˜i = (xi, ti) where Σ(x˜i) =
Σi,Φ(x˜i) = Φi and Σ̂(x˜i) = Σ̂i. Here we use the fact that Σi only depends on
x˜i.
We can thus write
q̂− q˜ = n− 12
n∑
i=1
∫
(yi − µ̂i)T(T̂ (x˜)− T (x˜))d {I{x˜i ≤ x˜}} (28)
=
∫
(T̂ (x˜)− T (x˜))Td
{
n−
1
2
n∑
i=1
(yi − µ̂i)I{x˜i ≤ x˜}
}
(29)
Now since E(yi−µ̂i|x˜i) = 0 under (2.4), n−
1
2
∑n
i=1(yi−µ̂i)I{x˜i ≤ x˜} converges
to a Gaussian process in x˜. Using that fact and T̂ (x˜)→p T (x˜) it can be shown
that ∫
(T̂ (x˜)− T (x˜))Td
{
n−
1
2
n∑
i=1
(yi − µ̂i)I{x˜i ≤ x˜}
}
= op(1). (30)
This means that q̂ and q˜ are asymptotically equivalent, and we can examine
the limiting behavior of q˜ to understand the limiting behavior of q̂.
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Now, ignoring the intercept α0 for notational simplicity,
q˜ = n−
1
2
n∑
i=1
(yi − µ̂i)TTi (31)
= n−
1
2
n∑
i=1
(yi −Xiα)TTi − n− 12
n∑
i=1
(α̂−α)TXTi Ti (32)
= n−
1
2
n∑
i=1
(yi −Xiα)TTi − n− 12
n∑
i=1
Ui(α)Tn−1
n∑
i=1
(XTi Ti) + op(1) (33)
= n−
1
2
n∑
i=1
{(yi −Xiα)TTi − Ui(α)TE(XTi Ti)}+ op(1) (34)
= n−
1
2
n∑
i=1
Qi + op(1) (35)
where Ui(α) corresponds to the influence function for α̂ from a null parametric
model and Qi = (yi−Xiα)TTi−Ui(α)TE(XTi Ti). Thus, clearly q˜ has a limiting
normal distribution by the central limit theorem, which further suggests that the
asymptotic distribution of Q̂ is a mixture of χ21s where the mixing probabilities
are given by the eigenvalues of Cov(Qi).
S.2 The voom procedure
Let rijt be the read count from individual i for gene j at time t. Li =
∑G
j=1 rijt
is then the library size, that can vary from one sample to another. Law and
others (2014) propose the following transformation to obtain log-counts per
million value from sample i for gene g:
yijt = log2
(
106
0.5 + rijt
1 + Li
)
(36)
Counts are offset away from zero by 0.5 to avoid taking the log of zero (and
this also reduces the variability of log-cpm for low expression genes) while the
library size is offset by 1 to ensure that any log-cpm is below 1 million. Let X
be the design matrix of factors that are suspected to influence gene expression.
The voom procedure to estimate mean-variance weights proposed by Law
and others (2014) is the following:
1. α̂ is the OLS estimate from the linear model: yijt = x
T
i α + εijt with
εijt ∼ N (0, σj)
2. Let ŝj =
√√√√ n∑
i=1
(
yijt − xTi α̂
)2
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3. Let r˜j =
1
n
n∑
i=1
yijt+log2
(
n∏
i=1
(1 +
G∑
g=1
rijt)
)1/n
−log2(106) be the average
log-count value.
4. f̂(·) is the predictor obtained from the LOWESS regression (Cleveland,
1979) of
√
ŝj over r˜j . The final precision weights are then defined as
follows:
wijt =
[
f̂
(
xTi α̂+ log2(1 +
G∑
g=1
rijt)− log2(106)
)]−4
(37)
S.3 Additional simulations
Here we provide additional simulation results in the realistic setting of a small
sample size. We generated data for 6 individuals, each measured at 3 time
points according to the scenario described in Law and others (2014), using the
script provided in their Supplementary Material:
yijt = log
(
(aij + 0.5)10
6∑
j aij + 1
)
+ γjtit + ijt (38)
where tit ∈ {1, 2, 3}, ijt ∼ N(0, 0.05), aij ∼ Pois(λij), λij ∼ Gamma( κij40mij ,
40mij
κijµij
), κij ∼ χ2(40), mij = 0.2+1/√µij , γj ∼ N(0, σγ), and µij follows an em-
pirical baseline distribution derived from real data, provided in supplementary
material of Law and others (2014). We set n = 18 with ni = 3, and gene sets
were constructed such that p ∈ (30, . . . , 400) and for every gene pair (j, j′) in the
set cor(aj ,aj′) > 0.8. σγ) varied among (0, 0.02, 0.05, 0.1, 0.15, 0.2, 0.25, 0.3).
The results are very similar to those for homogeneous gene sets, see Figure 6.
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